Charles Farkas - Jun 1, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M. Oliker for Charles Farkas by Power of Attorney
Stock symbol
CNMD
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 02:13 PM
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +1.52K +8.99% $0.00 18.4K Jun 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -1.52K -100% $0.00* 0 Jun 1, 2021 Common Stock 1.52K $0.00 Direct
transaction CNMD Rsus (restricted Stock Units) Award $0 +812 $0.00 812 Jun 1, 2021 Common Stock 812 $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +865 $0.00 865 Jun 1, 2021 Common Stock 865 $138.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.